Cargando…

A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

BACKGROUND: Clarithromycin-based therapy is important for Helicobacter pylori eradication treatment. However, clarithromycin may increase cardiovascular risk. Hence, we investigated the association between clarithromycin use and outcomes in adults with stable coronary heart disease (CHD) and subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yen-Chun, Li, Yi-Da, Yu, Ben-Hui, Chen, Yi-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469559/ https://www.ncbi.nlm.nih.gov/pubmed/36096732 http://dx.doi.org/10.1186/s12876-022-02498-1

Ejemplares similares

Does Helicobacter pylori Eradication Reduce the Risk of Open Angle Glaucoma in Patients With Peptic Ulcer Disease?
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Effect of licorice versus bismuth on eradication of Helicobacter pylori in patients with peptic ulcer disease
por: Momeni, Ali, et al.
Publicado: (2014)

Comparison of efficacy and pharmacoeconomics of two Helicobacter pylori eradication regimens in peptic ulcer disease
por: Kubra Hussaini, Syeda Zaineb, et al.
Publicado: (2018)

Saliva Secretion and Efficacy of Helicobacter Pylori Eradication in Peptic Ulcer Patients
por: Vahedi, M., et al.
Publicado: (2011)

Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study
por: Fang, Chu-Wen, et al.
Publicado: (2020)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

Antral Helicobacter Pylori Infection, Hypergastrinemia and Peptic Ulcers: Effect of Eradicating the Organism
por: Park, Sill Moo, et al.
Publicado: (1993)

Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study
por: Lai, Jung-Nien, et al.
Publicado: (2022)

Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients
por: Chang, Shen Shong, et al.
Publicado: (2015)

Acute Peptic Ulcer Disease Caused by Non-Helicobacter pylori-Helicobacter
por: Da Cunha, Teresa, et al.
Publicado: (2021)

Simple Patch Closure for Perforated Peptic Ulcer in Children Followed by Helicobacter Pylori Eradication
por: Yildiz, Turan, et al.
Publicado: (2014)

Dramatic shift in the epidemiology of peptic ulcer in Japan: the impact of Helicobacter pylori eradication therapy
por: Lee, K. D., et al.
Publicado: (2021)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia
por: Chan, Chung-Chuan, et al.
Publicado: (2015)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis
por: Kowada, Akiko, et al.
Publicado: (2022)

Helicobacter pylori Infection and Peptic Ulcer Disease in Patients with Liver Cirrhosis
por: Kim, Dong Joon, et al.
Publicado: (2008)

Assessment of Risk Factors of Helicobacter Pylori Infection and Peptic Ulcer Disease
por: Mhaskar, Rahul S, et al.
Publicado: (2013)

Antigenic Diversity and Serotypes of Helicobacter pylori Associated with Peptic Ulcer Diseases
por: Park, Seon Mee, et al.
Publicado: (1998)

Analysis of risk factors for ulcer recurrence and upper gastrointestinal bleeding in children with peptic ulcer treated with Helicobacter pylori eradication therapy
por: Li, Ruixue, et al.
Publicado: (2023)

Helicobacter Pylori Infection and Serum Pepsinogen I Concentration in Peptic Ulcer Patients: Effect of Bacterial Eradication
por: Park, Sill Moo, et al.
Publicado: (1996)

Prevalence of Helicobacter pylori Infection in Patients with Peptic Ulcer Diseases and Non-Ulcer Dyspepsia
por: Lee, Hyo Rang, et al.
Publicado: (1993)

Helicobacter pylori, peptic ulcer and gastric cancer in China.
por: Lam, S. K., et al.
Publicado: (1998)

Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer
por: Vu, Thanh Binh, et al.
Publicado: (2022)

Diagnosis, Treatment, and Outcome in Patients with Bleeding Peptic Ulcers and Helicobacter pylori Infections
por: Huang, Ting-Chun, et al.
Publicado: (2014)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers
por: Silva, Fernando Marcuz, et al.
Publicado: (2015)

Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection
por: Kasai, Chika, et al.
Publicado: (2016)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis
por: Chang, Young Woon, et al.
Publicado: (2019)

The use of non‐invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance
por: Mommersteeg, Michiel C., et al.
Publicado: (2023)

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study
por: Ben Mansour, Khansa, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m6t7se55rie8hg68ha8u7rh9hh